Thyroid cancer development and progression: Emerging role of cancer stem cells

Minerva Endocrinologica

Volumn 37, Issue 2, 2012, Pages 103-115

  Malaguarnera, R ^a   Morcavallo, A ^a   Giuliano, S ^a   Belfiore, A ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Thyroid gland; Thyroid neoplasms stem cells

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CALCITONIN; CD45 ANTIGEN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; SONIC HEDGEHOG PROTEIN; STEM CELL FACTOR RECEPTOR; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR GATA 4; VERAPAMIL; WNT PROTEIN;

ANAPLASTIC THYROID CANCER; CANCER GROWTH; CANCER PREVENTION; CANCER STEM CELL; CARCINOGENESIS; CELL ISOLATION; CELL PROLIFERATION; DIFFERENTIATED THYROID CANCER; DOWN REGULATION; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; HASHIMOTO DISEASE; HUMAN; IN VITRO STUDY; MICROCHIMERISM; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THYROID CANCER; THYROID GLAND; THYROID PAPILLARY CARCINOMA; ULTIMOBRANCHIAL BODY;

ANIMALS; CARCINOMA; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MODELS, GENETIC; MUTATION; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; ORGAN SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84867305990     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Fagin JA. Genetics of papillary thyroid cancer initiation: implications for therapy. Trans Am Clin Climatol Assoc 2005;116:259-69; discussion 69-71.
2. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292-306.
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
4. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992;72:667-97.
5. Lan L, Cui D, Nowka K, Derwahl M. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab 2007;92:3681-8. (Pubitemid 47435356)
6. Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simoes M. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 2003;16:43-8. (Pubitemid 36152685)
7. Thomas T, Nowka K, Lan L, Derwahl M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid 2006;16:537-44. (Pubitemid 44066260)
8. Thomas D, Friedman S, Lin RY. Thyroid stem cells: lessons from normal development and thyroid cancer. Endocr Relat Cancer 2008;15:51-8. (Pubitemid 351449727)
9. Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol 2008;198:471-87.
10. Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res 2010;70:8874-85.
11. Malaguarnera R, Frasca F, Garozzo A, Giani F, Pandini G, Vella V et al. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab 2011;96:766-74.
12. Hoyes AD, Kershaw DR. Anatomy and development of the thyroid gland. Ear Nose Throat J 1985;64:318-33. (Pubitemid 15227917)
13. Rogers MP, Whybrow PC. Clinical hypothyroidism occurring during lithium treatment: two case histories and a review of thyroid function in 19 patients. Am J Psychiatry 1971;128:158-63.
14. Missero C, Cobellis G, De Felice M, Di Lauro R. Molecular events involved in differentiation of thyroid follicular cells. Mol Cell Endocrinol 1998;140:37-43. (Pubitemid 28375209)
15. De Felice M, Di Lauro R. Minireview: Intrinsic and extrinsic factors in thyroid gland development: an update. Endocrinology 2011;152:2948-56.
16. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004;25:722-46. (Pubitemid 39362295)
17. Parlato R, Rosica A, Rodriguez-Mallon A, Affuso A, Postiglione MP, Arra C et al. An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev Biol 2004;276:464-75. (Pubitemid 39592407)
18. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M et al. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci U S A 2002;99:15462-7. (Pubitemid 35407483)
19. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001;19:271-8. (Pubitemid 32721093)
20. Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002;20:11-20. (Pubitemid 34118906)
21. Arceci RJ, King AA, Simon MC, Orkin SH, Wilson DB. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 1993;13:2235-46. (Pubitemid 23097702)
22. Duncan SA, Manova K, Chen WS, Hoodless P, Weinstein DC, Bachvarova RF et al. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc Natl Acad Sci U S A 1994;91:7598-602. (Pubitemid 24238232)
23. Malaguarnera R, Mandarino A, Mazzon E, Vella V, Gangemi P, Vancheri C et al. The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer 2005;12:953-71.
24. Burstein DE, Nagi C, Wang BY, Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 2004;35:465-73. (Pubitemid 38507084)
25. Rios Moreno MJ, Galera-Ruiz H, De Miguel M, Lopez MI, Illanes M, Galera-Davidson H. Inmunohistochemical profile of solid cell nest of thyroid gland. Endocr Pathol 2011;22:35-9.
26. Damante G, Di Lauro R. Thyroid-specific gene expression. Biochim Biophys Acta 1994;1218:255-66. (Pubitemid 24252520)
27. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 1998;19:87-90. (Pubitemid 28242031)
28. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631-9.
29. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, Anastassiadis K et al. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 1998;19:395-8. (Pubitemid 28357915)
30. Damante G, Tell G, Di Lauro R. A unique combination of transcription factors controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol 2001;66:307-56.
31. Arufe MC, Lu M, Lin RY. Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun 2009;381:264-70.
32. Lania G, Zhang Z, Huynh T, Caprio C, Moon AM, Vitelli F et al. Early thyroid development requires a Tbx1-Fgf8 pathway. Dev Biol 2009;328:109-17.
33. Fagman H, Grande M, Edsbagge J, Semb H, Nilsson M. Expression of classical Cadherins in thyroid development: maintenance of an epithelial phenotype throughout organogenesis. Endocrinology 2003;144:3618-24. (Pubitemid 36904441)
34. Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 2009;29:3722-37.
35. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci 2008;121:727-35. (Pubitemid 351578108)
36. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001;105:829-41. (Pubitemid 32635085)
37. Hoshi N, Kusakabe T, Taylor BJ, Kimura S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology 2007;148:4251-8. (Pubitemid 47295711)
38. Renne C, Ramos Lopez E, Steimle-Grauer SA, Ziolkowski P, Pani MA, Luther C et al. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomai immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol Metab 2004;89:5810-4. (Pubitemid 39518475)
39. Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001;358:2034-8. (Pubitemid 34084826)
40. Fierabracci A, Castagna M, Baschieri L. Calcitonin and somatostatin containing C cells in rat and human thyroid. Immunohistochemical study by a double-staining method. Pathologica 1993;85:467-74. (Pubitemid 24029660)
41. Gibson WG, Peng TC, Croker BP. Age-associated C-cell hyperplasia in the human thyroid. Am J Pathol 1982;106:388-93. (Pubitemid 12192661)
42. Gibelli B, El-Fattah A, Giugliano G, Proh M, Grosso E. Thyroid stem cells-danger or resource? Acta Otorhinolaryngol Ital 2009;29:290-5.
43. Lowry WE, Richter L. Signaling in adult stem cells. Front Biosci 2007;12:3911-27.
44. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P et al. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol 2004;17:819-26. (Pubitemid 38849387)
45. Cameselle-Teijeiro J, Febles-Perez C, Sobrinho-Simoes M. Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract 1995;191:1214-21. (Pubitemid 26060404)
46. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007;148:1797-803. (Pubitemid 46457095)
47. Zheng X, Cui D, Xu S, Brabant G, Derwahl M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol 2010;37:307-15.
48. Friedman S, Lu M, Schultz A, Thomas D, Lin RY. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One 2009;4:e5395.
49. Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 2008;114:23-37. (Pubitemid 351998752)
50. Chen CY, Kimura H, Landek-Salgado MA, Hagedorn J, Kimura M, Suzuki K et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology 2009;150:492-9.
51. Schoorlemmer J, Jonk L, Sanbing S, van Puijenbroek A, Feijen A, Kruijer W. Regulation of Oct-4 gene expression during differentiation of EC cells. Mol Biol Rep 1995;21:129-40. (Pubitemid 2625929)
52. Zhu W, Hai T, Ye L, Cote GJ. Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity. J Clin Endocrinol Metab 2010;95:439-44.
53. Lin RY New insights into thyroid stem cells. Thyroid 2007;17:1019-23.
54. Klonisch T, Hoang-Vu C, Hombach-Klonisch S. Thyroid stem cells and cancer. Thyroid 2009;19:1303-15.
55. Farid NR, Shi Y, Zou M. Molecular basis of thyroid cancer. Endocr Rev 1994;15:202-32. (Pubitemid 24129183)
56. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11. (Pubitemid 33041634)
57. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-44.
58. Takano T. Fetal cell carcinogenesis of the thyroid: a hypothesis for better understanding of gene expression profile and genomic alternation in thyroid carcinoma. Endocr J 2004;51:509-15. (Pubitemid 40209016)
59. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003;63:1454-7. (Pubitemid 36373628)
60. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, Kuma K et al. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 1999;59:4542-5. (Pubitemid 29428954)
61. Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathol Int 2006;56:485-9. (Pubitemid 44258848)
62. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V et al. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 2002;87:245-54. (Pubitemid 34084698)
63. Park CH, Bergsagel DE, McCulloch EA. Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 1971;46:411-22.
64. Lin RY. Thyroid cancer stem cells. Nat Rev Endocrinol 2011;7:609-16.
65. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-64.
66. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15. (Pubitemid 351636299)